Cigarette Smoker
15
1
4
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (15)
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers
Varenicline and Combined NRT for Smoking Cessation
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking
Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs
Project CASA in Promoting Smoke-Free Indoor Air Policy in Mexican American Households
Validation of Biomarkers of Exposure and Host Response
Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers
Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers
Tailored Smoking Cessation Intervention in Promoting Sexual and Gender Minority Smokers to Quit Smoking
APPSPIRE App in Preventing Students From Smoking
Enhanced Smoking Cessation for University Students
Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers